A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
President Lai addresses Taiwan dollar rise, reassures public on trade talks
05/06/2025 11:40 AM - Politics
Japan-Taiwan-U.S. forming 'semiconductor iron triangle': Ex-Japan minister
05/06/2025 11:19 AM - Politics
U.S. House passes bills on Taiwan engagement, int'l participation
05/06/2025 10:50 AM - Society
Rain predicted in northern, eastern Taiwan on Tuesday
05/06/2025 10:42 AM - Business
U.S. dollar down in Taipei trading
05/06/2025 10:11 AM